½ÃÀ庸°í¼­
»óǰÄÚµå
1305177

¼¼°èÀÇ ÀÚµ¿ ³»½Ã°æ Àç󸮱⠽ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)

Global Automated Endoscope Reprocessors Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 163 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÚµ¿ ³»½Ã°æ Àç󸮱⠽ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023-2030³â µ¿¾È 8.12%ÀÇ CAGR·Î 2022³â 4¾ï 3,532¸¸ ´Þ·¯¿¡¼­ 2030³â 8¾ï 1,294¸¸ ´Þ·¯¿¡ À°¹ÚÇÏ´Â ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ÀÚµ¿ ³»½Ã°æ Àç󸮱â(AER)´Â ¿¬¼º ³»½Ã°æÀ» »ç¿ë ÈÄ ¼¼Ã´ ¹× ¼Òµ¶ÇÏ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. AERÀº ³»½Ã°æÀÇ ¼¼Ã´ ¹× ¼Òµ¶ °úÁ¤À» ÀÚµ¿È­Çϵµ·Ï ¼³°èµÇ¾úÀ¸¸ç, ÀÌ´Â °¨¿°À» ¿¹¹æÇϰí ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ´Ü°èÀÔ´Ï´Ù. ³ôÀº ¼öÁØÀÇ ¼Òµ¶Á¦¿Í ÀÚµ¿ ¼¼Ã´ »çÀÌŬÀ» °áÇÕÇÏ¿© ³»½Ã°æ¿¡ ³²¾ÆÀÖ´Â »ý¹°ÇÐÀû ¹°Áú°ú ¿À¿° ¹°ÁúÀ» Á¦°ÅÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

³»½Ã°æ ¼ö¼úÀÌ Àü ¼¼°èÀûÀ¸·Î È®»êµÇ°í ÀÖ´Â °ÍÀÌ AER ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ³»½Ã°æ ½Ã¼úÀº ¼ÒÈ­±â, È£Èí±â, ºñ´¢±â ÁúȯÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÁúȯÀÇ Áø´Ü ¹× Ä¡·á µµ±¸·Î º¸ÆíÈ­µÇ°í ÀÖÀ¸¸ç, AER »ç¿ë¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã¿Í ÁöħÀÌ °­È­µÊ¿¡ µû¶ó ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ FDA¿Í À¯·´ EMA´Â AERÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ AERÀÇ ¼³°è, ½ÃÇè ¹× »ç¿ë¿¡ ´ëÇÑ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã¼³ÀÇ °¨¿° ¿¹¹æ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ AER¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀûÀýÇÏ°Ô ¼¼Ã´ ¹× ¼Òµ¶µÈ ³»½Ã°æÀº °¨¿°¿ø ÀüÆÄ¸¦ ¹æÁöÇϰí ÀÇ·á °ü·Ã °¨¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ÇʼöÀûÀ̸ç, AERÀÇ ±â¼ú ¹ßÀüÀ¸·Î º¸´Ù È¿À²ÀûÀ̰í È¿°úÀûÀÎ ¼¼Ã´ ¹× ¼Òµ¶ ÇÁ·Î¼¼½º°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. »õ·Î¿î AERÀº ÀÚµ¿ ´©Ãâ Å×½ºÆ®, ÀüÀÚ ÃßÀû ½Ã½ºÅÛ, °í±Þ ¼Òµ¶ »çÀÌŬ µîÀÇ ±â´ÉÀ¸·Î ¼³°èµÇ¾î Àçó¸® °øÁ¤ÀÇ ¾ÈÀü¼º°ú ½Å·Ú¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÏȸ¿ë ³»½Ã°æ ¹× ¾×¼¼¼­¸®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ±â±â¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â AERÀ¸·Î ½ÃÀåÀÌ À̵¿Çϰí ÀÖ½À´Ï´Ù. Á¦Á¶¾÷üµéÀº ÀÇ·á ½Ã¼³ÀÇ º¯È­ÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ Àç»ç¿ë ¹× ÀÏȸ¿ë ±â±â¸¦ ¸ðµÎ Àçó¸®ÇÒ ¼ö ÀÖ´Â AERÀ» °³¹ßÇϰí ÀÖÀ¸¸ç, AERÀº ºñ¿ëÀÌ ¸¹ÀÌ µå´Â ¼öÀÛ¾÷ ¼¼Ã´ ¹× ¼Òµ¶ °úÁ¤ÀÇ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ¾î ÀÇ·á ½Ã¼³¿¡ ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀÔ´Ï´Ù. ¼Ö·ç¼ÇÀÔ´Ï´Ù. ¶ÇÇÑ ³»½Ã°æÀÇ ¼ö¸íÀ» ¿¬ÀåÇϰí ÀæÀº ±³Ã¼ Çʿ伺À» ÁÙÀÌ´Â µ¥µµ µµ¿òÀÌ µË´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ÀÚµ¿ ³»½Ã°æ Àç󸮱⠼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÚµ¿ ³»½Ã°æ Àç󸮱⠻ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­:

ÀÚµ¿ ³»½Ã°æ Àç󸮱⠽ÃÀå º¸°í¼­ÀÇÀÌ ¼½¼ÇÀº ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ ÇâÈÄ ±âȸ¸¦ ÅëÇØ °¢ Á¦Ç° ¹× ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.

Á¦Ç° À¯Çüº°

  • ´ÜÀÏ ºÐÁö ÀÚµ¿ ³»½Ã°æ Àç󸮱â
  • µà¾ó ºÐÁö ÀÚµ¿ ³»½Ã°æ Àç󸮱â

¸ð´Þ¸®Æ¼º°

  • µ¶¸³Çü ÀÚµ¿ ³»½Ã°æ Àç󸮱â
  • Ź»óÇü ÀÚµ¿ ³»½Ã°æ Àç󸮱â

ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ
  • º´¿ø
  • Áø·á¼Ò

Áö¿ªº° ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÚµ¿ ³»½Ã°æ Àç󸮱⠽ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ÀÚµ¿ ³»½Ã°æ Àç󸮱â - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¸Å·Âµµ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå COVID-19 ¹ß»ýÀÇ ¿µÇ⠺м®

Á¦6Àå ÀÚµ¿ ³»½Ã°æ Àç󸮱⠼¼°è ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • °³¿ä : Á¦Ç° À¯Çüº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : Á¦Ç° À¯Çüº°
  • ½Ì±Û ºÐÁö ÀÚµ¿ ³»½Ã°æ Àç󸮱â
  • µà¾ó ºÐÁö ÀÚµ¿ ³»½Ã°æ Àç󸮱â

Á¦7Àå ÀÚµ¿ ³»½Ã°æ Àç󸮱⠼¼°è ½ÃÀå ºÐ¼® : ¸ð´Þ¸®Æ¼º°

  • ¸ð´Þ¸®Æ¼º° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¸ð´Þ¸®Æ¼º° ºÐ¼®
  • µ¶¸³Çü ÀÚµ¿ ³»½Ã°æ Àç󸮱â
  • º¥Ä¡ÅéÇü ÀÚµ¿ ³»½Ã°æ Àç󸮱â

Á¦8Àå ÀÚµ¿ ³»½Ã°æ Àç󸮱⠼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • ÃÖÁ¾»ç¿ëÀÚº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ÃÖÁ¾»ç¿ëÀÚº° ºÐ¼®
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø
  • Ŭ¸®´Ð

Á¦9Àå ÀÚµ¿ ³»½Ã°æ Àç󸮱⠼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÀÚµ¿ ³»½Ã°æ Àç󸮱⠱â¾÷ °æÀï »óȲ

  • ÀÚµ¿ ³»½Ã°æ Àç󸮱⠽ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÀμöÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦11Àå ±â¾÷ °³¿ä

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Custom Ultrasonics Inc.
  • STERIS Plc.
  • Hoya Corporation
  • Olympus Corporation
  • Advanced Sterilization Products Services Inc
  • Laboratory Anios
  • Getinge AB
  • Metull Zug AG
  • Steelco S.p.A.
  • Cantel Medical Corp.
  • Johnson & Johnson.

*Âü°í : ±â¾÷ °³¿ä¿¡¼­ À繫 ³»¿ëÀ̳ª ÃÖ±ÙÀÇ µ¿ÇâÀº ºñ°ø°³ ±â¾÷ÀÇ °æ¿ì ÀÔ¼ö °¡´É ¿©ºÎ¿¡ µû¶ó ´Þ¶óÁö°Å³ª Á¦°øµÇÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.

ksm 23.08.22

The global demand for Automated Endoscope Reprocessors Market is presumed to reach the market size of nearly USD 812.94 MN by 2030 from USD 435.32 MN in 2022 with a CAGR of 8.12% under the study period 2023 - 2030. Regarding volume, the market was calculated XX Units in 2022 and forecast to touch XX Units by 2030 with a CAGR of XX% during 2023-2030.

Automated Endoscope Reprocessors (AERs) are medical devices used to clean and disinfect flexible endoscopes after use. Flexible endoscopes are long, thin instruments with a light and camera on the end that are used to visualize and perform procedures inside the body, such as in the gastrointestinal tract or respiratory system. AERs are designed to automate the process of cleaning and disinfecting endoscopes, which is a critical step in preventing infections and ensuring patient safety. AERs use a combination of high-level disinfectants and automated cleaning cycles to remove any remaining biological material or contaminants on the endoscope.

Market Dynamics:

The increasing prevalence of endoscopic procedures worldwide is a major driver of the AERs market. Endoscopic procedures are becoming more common as a diagnostic and treatment tool for various medical conditions, including gastrointestinal, respiratory, and urological disorders. The increasing regulatory scrutiny and guidelines on the use of AERs have led to increased demand for these devices. US FDA and the European EMA have set strict guidelines for the design, testing, and use of AERs to ensure their safety and efficacy. The growing focus on infection control in healthcare facilities has also driven the demand for AERs. Properly cleaned and disinfected endoscopes are critical for preventing the transmission of infectious agents and reducing the risk of healthcare-associated infections. Technological advancements in AERs have led to the development of more efficient and effective cleaning and disinfection processes. Newer AERs are designed with features such as automated leak testing, electronic tracking systems, and advanced disinfection cycles that improve the safety and reliability of the reprocessing process. The growing demand for single-use endoscopes and accessories has led to a shift in the market towards AERs that can handle these devices. Manufacturers are developing AERs that can reprocess both reusable and single-use devices to meet the changing needs of healthcare facilities. AERs are a cost-effective solution for healthcare facilities as they can reduce the need for costly manual cleaning and disinfection processes. They can also help to extend the lifespan of endoscopes, reducing the need for frequent replacements.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of automated endoscope reprocessors. The growth and trends of automated endoscope reprocessors industry provide a holistic approach to this study.

Market Segmentation:

This section of the automated endoscope reprocessors market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Single Basin Automated Endoscope Reprocessors
  • Dual Basin Automated Endoscope Reprocessors

By Modality

  • Standalone Automated Endoscope Reprocessors
  • Bench Top Automated Endoscope Reprocessors

By End User

  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Automated Endoscope Reprocessors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the automated endoscope reprocessors market include Custom Ultrasonics Inc., STERIS Plc., Hoya Corporation, Olympus Corporation, Advanced Sterilization Products Services Inc, Laboratory Anios, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., Johnson & Johnson. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . AUTOMATED ENDOSCOPE REPROCESSORS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Modality
    • 3.7.3 Market Attractiveness Analysis By End User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Single Basin Automated Endoscope Reprocessors Historic and Forecast Sales by Regions
  • 6.5 Dual Basin Automated Endoscope Reprocessors Historic and Forecast Sales by Regions

7 . GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET ANALYSIS BY MODALITY

  • 7.1 Overview by Modality
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Modality
  • 7.4 Standalone Automated Endoscope Reprocessors Historic and Forecast Sales by Regions
  • 7.5 Bench Top Automated Endoscope Reprocessors Historic and Forecast Sales by Regions

8 . GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
  • 8.5 Hospitals Historic and Forecast Sales by Regions
  • 8.6 Clinics Historic and Forecast Sales by Regions

9 . GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data  Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data  Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data  Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data  Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data  Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE AUTOMATED ENDOSCOPE REPROCESSORS COMPANIES

  • 10.1. Automated Endoscope Reprocessors Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF AUTOMATED ENDOSCOPE REPROCESSORS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Custom Ultrasonics Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. STERIS Plc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Hoya Corporation
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Olympus Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Advanced Sterilization Products Services Inc
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Laboratory Anios
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Getinge AB
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Metull Zug AG
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Steelco S.p.A.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Cantel Medical Corp.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Johnson & Johnson.
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦